379 related articles for article (PubMed ID: 24283844)
1. Local reactions from subcutaneous allergen immunotherapy.
Coop CA
Immunotherapy; 2013 Dec; 5(12):1339-45. PubMed ID: 24283844
[TBL] [Abstract][Full Text] [Related]
2. Patient perceptions regarding local reactions from allergen immunotherapy injections.
Coop CA; Tankersley MS
Ann Allergy Asthma Immunol; 2008 Jul; 101(1):96-100. PubMed ID: 18681091
[TBL] [Abstract][Full Text] [Related]
3. Dose adjustment practices among allergists for local reactions to immunotherapy.
Coop CA; Tankersley MS
Ann Allergy Asthma Immunol; 2007 Jul; 99(1):77-81. PubMed ID: 17650834
[TBL] [Abstract][Full Text] [Related]
4. The rate of systemic reactions to immunotherapy injections is the same whether or not the dose is reduced after a local reaction.
Kelso JM
Ann Allergy Asthma Immunol; 2004 Feb; 92(2):225-7. PubMed ID: 14989390
[TBL] [Abstract][Full Text] [Related]
5. The LOCAL Study: Local reactions do not predict local reactions in allergen immunotherapy.
Calabria CW; Coop CA; Tankersley MS
J Allergy Clin Immunol; 2009 Oct; 124(4):739-44. PubMed ID: 19767075
[TBL] [Abstract][Full Text] [Related]
6. Increased frequency of large local reactions among systemic reactors during subcutaneous allergen immunotherapy.
Roy SR; Sigmon JR; Olivier J; Moffitt JE; Brown DA; Marshall GD
Ann Allergy Asthma Immunol; 2007 Jul; 99(1):82-6. PubMed ID: 17650835
[TBL] [Abstract][Full Text] [Related]
7. Adverse effects and fatalities associated with subcutaneous allergen immunotherapy.
Bukantz SC; Bagg AS; Lockey RF
Clin Allergy Immunol; 2008; 21():455-68. PubMed ID: 18828523
[No Abstract] [Full Text] [Related]
8. Risk factors for systemic reactions to allergen-specific subcutaneous immunotherapy.
Iglesias-Cadarso A; Hernández-Weigand P; Reaño M; Pérez-Pimiento A; Vargas Núñez JA; de la Torre F
J Investig Allergol Clin Immunol; 2010; 20(7):621-2. PubMed ID: 21314007
[No Abstract] [Full Text] [Related]
9. The REPEAT study: recognizing and evaluating periodic local reactions in allergen immunotherapy and associated systemic reactions.
Calabria CW; Stolfi A; Tankersley MS
Ann Allergy Asthma Immunol; 2011 Jan; 106(1):49-53. PubMed ID: 21195945
[TBL] [Abstract][Full Text] [Related]
10. Allergen immunotherapy: an updated review of safety.
James C; Bernstein DI
Curr Opin Allergy Clin Immunol; 2017 Feb; 17(1):55-59. PubMed ID: 27906697
[TBL] [Abstract][Full Text] [Related]
11. [New administration routes for immunotherapy].
Martorell Aragonés A
Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
[TBL] [Abstract][Full Text] [Related]
12. Local and systemic reactions to subcutaneous allergen immunotherapy: Ten years' experience in a pediatric clinic.
Nacaroglu HT; Erdem SB; Sumer O; Karaman S; Unsal Karkıner CS; Asilsoy S; Gunay I; Can D
Ann Allergy Asthma Immunol; 2016 Apr; 116(4):349-53. PubMed ID: 26905639
[TBL] [Abstract][Full Text] [Related]
13. Immune mechanisms of allergen-specific sublingual immunotherapy.
Moingeon P; Batard T; Fadel R; Frati F; Sieber J; Van Overtvelt L
Allergy; 2006 Feb; 61(2):151-65. PubMed ID: 16409190
[TBL] [Abstract][Full Text] [Related]
14. T-cell responses during allergen-specific immunotherapy.
Maggi E; Vultaggio A; Matucci A
Curr Opin Allergy Clin Immunol; 2012 Feb; 12(1):1-6. PubMed ID: 22157159
[TBL] [Abstract][Full Text] [Related]
15. Safety of subcutaneous immunotherapy with inhalant allergen extracts: a single-center 30-year experience from Turkey.
Kartal O; Gulec M; Caliskaner Z; Musabak U; Sener O
Immunopharmacol Immunotoxicol; 2015 Jun; 37(3):280-6. PubMed ID: 25858053
[TBL] [Abstract][Full Text] [Related]
16. Fungal immunotherapy in patients with allergic fungal sinusitis.
Greenhaw B; deShazo RD; Arnold J; Wright L
Ann Allergy Asthma Immunol; 2011 Nov; 107(5):432-6. PubMed ID: 22018615
[TBL] [Abstract][Full Text] [Related]
17. Allergen-related approaches to immunotherapy.
Rolland JM; Gardner LM; O'Hehir RE
Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
[TBL] [Abstract][Full Text] [Related]
18. [The mechanisms of allergen-specific immunotherapy more clear].
Rak S
Lakartidningen; 2008 Jun 25-Jul 1; 105(26-27):1935-7. PubMed ID: 18681375
[No Abstract] [Full Text] [Related]
19. Intralymphatic injections as a new administration route for allergen-specific immunotherapy.
Martínez-Gómez JM; Johansen P; Erdmann I; Senti G; Crameri R; Kündig TM
Int Arch Allergy Immunol; 2009; 150(1):59-65. PubMed ID: 19339803
[TBL] [Abstract][Full Text] [Related]
20. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile.
Calderón MA; Simons FE; Malling HJ; Lockey RF; Moingeon P; Demoly P
Allergy; 2012 Mar; 67(3):302-11. PubMed ID: 22150126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
